Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gilead Gets Injunction Against Abbott And India’s Lyka On Amphotericin Brands

This article was originally published in PharmAsia News

Executive Summary

What’s in a name? Everything, Gilead would say going by the latest injunction it obtained against Abbott and Indian drug maker Lyka. Gilead says the two drug companies were marketing confusingly similar generic brands of its anti-fungal amphotericin. But is there a bigger angle to the story?

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC083220

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel